• MSD investment confirms thriving biopharmaceutical hub europeanpharmaceuticalreview
    June 12, 2017
    BioPharmaChem Ireland, the Ibec group that represents business in the sector, said the announcement of MSD to invest €280 million in Ireland over the next three years bolsters the country’s status as a thriving hub for the biopharmaceutical sector.
PharmaSources Customer Service